Login / Signup
NEJM at ESMO - Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
Eric J Rubin
Oladapo O Yeku
Stephen Morrissey
Published in:
The New England journal of medicine (2024)
Keyphrases
</>
skin cancer